Food
Period Ending | Period | Revenue ( m) | Pre-tax ( m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-24 | Interim | 3,880.40 | 340.50 | 194.10¢ | 38.10¢ |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 7,241.30 | 645.90 | 393.70¢ | 27.9 | 2.5 | +11% | 78.60¢ | 0.7% |
31-Dec-20 | 6,953.40 | 635.30 | 345.40¢ | 34.3 | n/a | -12% | 86.50¢ | 0.7% |
31-Dec-21 | 7,350.60 | 816.30 | 380.80¢ | 29.5 | 3.0 | +10% | 95.20¢ | 0.8% |
31-Dec-22 | 8,771.90 | 699.00 | 341.90¢ | 24.9 | n/a | -10% | 104.80¢ | 1.2% |
31-Dec-23 | 8,020.30 | 822.60 | 410.40¢ | 19.3 | 1.0 | +20% | 115.40¢ | 1.5% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 7,978.63 | 955.94 | 466.39¢ | 19.7 | 1.4 | +14% | 126.29¢ | 0.0% |
31-Dec-25 | 8,042.83 | 1,061.10 | 523.17¢ | 17.6 | 1.4 | +12% | 138.96¢ | 0.0% |
31-Dec-26 | 8,434.77 | 1,152.82 | 579.22¢ | 15.9 | 1.5 | +11% | 152.17¢ | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 27.94 | 19.27 | 27.17 | 0.82 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | Euro |
Share Price | 91.90 |
Change Today | 0.40 |
% Change | 0.44 % |
52 Week High | 96.3 |
52 Week Low | 73.9 |
Volume | 137,325 |
Shares Issued | 169.35m |
Market Cap | 15,563m |
Beta | 0.63 |
RiskGrade | 121 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 5 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 13 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 10-Oct-24 | 11-Apr-24 |
Paid | 08-Nov-24 | 10-May-24 |
Amount | 38.10¢ | 80.80¢ |
Time | Volume / Share Price |
17:13 | 1,458 @ 91.16 |
17:13 | 2,813 @ 91.70 |
17:12 | 118 @ 91.73 |
16:50 | 2,427 @ 92.00 |
16:35 | 60 @ 91.90 |
Chair | Tom Moran |
CEO | Edmond Scanlon |
CFO | Marguerite Larkin |
You are here: research